Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Other Non Operating Income (2016 - 2025)

vTv Therapeutics' Other Non Operating Income history spans 10 years, with the latest figure at $12000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 103.91% year-over-year to $12000.0; the TTM value through Dec 2025 reached -$27000.0, down 115.7%, while the annual FY2025 figure was -$27000.0, 82.0% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $12000.0 at vTv Therapeutics, up from -$34000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $3.9 million in Q4 2022 and bottomed at -$3.6 million in Q3 2023.
  • The 5-year median for Other Non Operating Income is $12000.0 (2025), against an average of -$41470.6.
  • The largest YoY upside for Other Non Operating Income was 1515.57% in 2023 against a maximum downside of 1003.23% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $634000.0 in 2021, then skyrocketed by 522.08% to $3.9 million in 2022, then crashed by 95.74% to $168000.0 in 2023, then plummeted by 282.74% to -$307000.0 in 2024, then soared by 103.91% to $12000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Other Non Operating Income are $12000.0 (Q4 2025), -$34000.0 (Q3 2025), and $12000.0 (Q2 2025).